The in vivo roles of endogenous NO derived from the entire NOS system in pulmonary emphysema have been examined in pharmacological studies with non-selective NOSs inhibitors, such as Nω-nitro-l-arginine methyl ester (l-NAME). The gene discussed is NOS1; the disease is pulmonary emphysema.